article thumbnail

Top Life Science News and Trends in 2023 at Xtalks

XTalks

In 2023, there were significant advancements and notable trends in the life sciences. These advancements and trends addressed important industry challenges and offered opportunities to foster innovations and solutions in areas including drug development, healthcare and medical devices.

article thumbnail

Streamlining development with containment in early drug discovery

Drug Discovery World

It may seem counterintuitive to spend time and money on planning for containment and delivery systems for a drug in the earliest stages of discovery when the chances of that molecule making it to market are still quite low. The increasing complexity of drug products has raised concern among pharmaceutical developers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Key findings from life sciences digital pathology adoption survey 

Drug Discovery World

Nearly three-fourths of life sciences organisations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia. AI is already powering drug discovery and development 82% of respondents that use digital pathology have begun to implement AI.

article thumbnail

XBB.1.5 Omicron Subvariant + FDA Approves AstraZeneca’s New Asthma Inhaler – Xtalks Life Science Podcast Ep. 93

XTalks

Ayesha also talked about the FDA approval of AstraZeneca’s asthma inhaler Airsupra, the first-in-class drug that contains both a beta agonist and corticosteroid. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Hear more about the new subvariant and why scientists are keeping a close eye on it.

article thumbnail

WHO Declares Omicron Variant of Concern + Seizure Drug Recalled Over Faulty Seal – Xtalks Life Science Podcast Ep. 39

XTalks

The team also talked about Sagent Pharmaceutical’s voluntary recall of several lots of its injectable seizure medication levetiracetam due to potential loss of sterility because of a container closure issue on the vials it comes packaged in. Seizure Drug from Sagent Pharmaceuticals Recalled Over Faulty Seal.

article thumbnail

4 Life Science Trends To Pay Attention To in 2021

XTalks

Both drug discovery and drug repurposing to manage and treat the disease will also continue as experts learn more about the virology and epidemiology of the novel SARS-CoV-2 coronavirus that wreaked havoc in 2020. These include monoclonal antibody drugs, which are attractive therapeutic agents owing to their targeted specificity.

article thumbnail

BioNTech Unveils Modular mRNA Factories for Africa + FDA Authorizes Eli Lilly Monoclonal Antibody Effective Against Omicron – Xtalks Life Science Podcast Ep. 49

XTalks

The modular production units are housed in containers that come equipped with raw starting materials and state-of-the-art technology for producing mRNA-based vaccines from start to finish, except for the fill-and-finish step, which will be carried out by local manufacturers.